x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

43 Resultado(s)

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Bayern
MÜNCHEN

AUSTRIA

STEIERMARK
GRAZ

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

ILE-DE-FRANCE
PARIS

SNT-III-001 MICONOS. A Phase III double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of Idebenone in the treatment of Friedreich Ataxia
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

FRANCA

ILE-DE-FRANCE
PARIS

MICONOS Extension : A Phase III Open-Label, Single-Group, Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIA

VENETO
PADOVA

DELOS: A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10,18 Year Old Patients with Duchenne Muscular Dystrophy - IT
Azienda Ospedaliera Universitaria di Padova - Campus Biomedico Pietro d'Abano
Laboratorio di Istomorfologia e Biologia Molecolare del Rene

REINO UNIDO

Greater London
LONDON

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

A Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Patients With Leber's Hereditary Optic Neuropathy (Phase II)
Newcastle University Institute for Ageing (NUIA), Newcastle Biomedicine
Wellcome Trust Centre for Mitochondrial Research (Institute of Neuroscience)

Ensaio (s) clínico (s) multinacional (ais)